BIOMAT Database Logo BIOMAT Database Logo

Metabolic disregulation in obese adolescents with sleep-disordered breathing before and after weight loss. 2013

K Van Hoorenbeeck, and H Franckx, and P Debode, and P Aerts, and J Ramet, and L F Van Gaal, and K N Desager, and W A De Backer, and S L Verhulst
Laboratory of Experimental Medicine and Pediatrics, University of Antwerp, Antwerp, Belgium. kim.vanhoorenbeeck@ua.ac.be

OBJECTIVE Sleep-disordered breathing (SDB) is prevalent in obesity. Weight loss is one of the most effective treatment options. The aim was to assess the association of SDB and metabolic disruption before and after weight loss. METHODS Obese adolescents were included when entering an in-patient weight loss program. Fasting blood analysis was performed at baseline and after 4-6 months. Sleep screening was done at baseline and at follow-up in case of baseline SDB. RESULTS 224 obese adolescents were included. Median age was 15.5 years (10.1-18.0) and mean BMI z-score was 2.74 ± 0.42. About 30% had SDB at baseline (N = 68). High-density lipoprotein (HDL)-cholesterol was associated with mean nocturnal oxygen saturation (<SaO2>) (partial r = 0.21; P = 0.002). Aspartate aminotransferase (ASAT) and alanine aminotransferase were related with oxygen desaturation index (partial r = -0.15; P = 0.03 and partial r = -0.15; P = 0.02), but this became insignificant after correction for sex. After weight loss, 24% had residual SDB. Linear regression showed an association between ASAT and <SaO2> (partial r = -0.34; P = 0.002). There were no significant correlations between improvements in laboratory measurements and sleep parameters. HDL-cholesterol improved in relation with the decrease in BMI z-score. CONCLUSIONS SDB at baseline was associated with higher levels of liver enzymes and lower HDL-cholesterol concentration. Improvements in sleep parameters were not associated with improvements in laboratory measurements.

UI MeSH Term Description Entries
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000410 Alanine Transaminase An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2. Alanine Aminotransferase,Glutamic-Pyruvic Transaminase,SGPT,Alanine-2-Oxoglutarate Aminotransferase,Glutamic-Alanine Transaminase,Alanine 2 Oxoglutarate Aminotransferase,Aminotransferase, Alanine,Aminotransferase, Alanine-2-Oxoglutarate,Glutamic Alanine Transaminase,Glutamic Pyruvic Transaminase,Transaminase, Alanine,Transaminase, Glutamic-Alanine,Transaminase, Glutamic-Pyruvic
D001219 Aspartate Aminotransferases Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1. Aspartate Aminotransferase,Aspartate Transaminase,Glutamic-Oxaloacetic Transaminase,SGOT,Aspartate Apoaminotransferase,Glutamate-Aspartate Transaminase,L-Aspartate-2-Oxoglutarate Aminotransferase,Serum Glutamic-Oxaloacetic Transaminase,Aminotransferase, Aspartate,Aminotransferase, L-Aspartate-2-Oxoglutarate,Aminotransferases, Aspartate,Apoaminotransferase, Aspartate,Glutamate Aspartate Transaminase,Glutamic Oxaloacetic Transaminase,Glutamic-Oxaloacetic Transaminase, Serum,L Aspartate 2 Oxoglutarate Aminotransferase,Serum Glutamic Oxaloacetic Transaminase,Transaminase, Aspartate,Transaminase, Glutamate-Aspartate,Transaminase, Glutamic-Oxaloacetic,Transaminase, Serum Glutamic-Oxaloacetic
D012891 Sleep Apnea Syndromes Disorders characterized by multiple cessations of respirations during sleep that induce partial arousals and interfere with the maintenance of sleep. Sleep apnea syndromes are divided into central (see SLEEP APNEA, CENTRAL), obstructive (see SLEEP APNEA, OBSTRUCTIVE), and mixed central-obstructive types. Apnea, Sleep,Hypersomnia with Periodic Respiration,Sleep-Disordered Breathing,Mixed Central and Obstructive Sleep Apnea,Sleep Apnea, Mixed,Sleep Apnea, Mixed Central and Obstructive,Sleep Hypopnea,Apnea Syndrome, Sleep,Apnea Syndromes, Sleep,Apneas, Sleep,Breathing, Sleep-Disordered,Hypopnea, Sleep,Hypopneas, Sleep,Mixed Sleep Apnea,Mixed Sleep Apneas,Sleep Apnea,Sleep Apnea Syndrome,Sleep Apneas,Sleep Apneas, Mixed,Sleep Disordered Breathing,Sleep Hypopneas
D015431 Weight Loss Decrease in existing BODY WEIGHT. Weight Reduction,Loss, Weight,Losses, Weight,Reduction, Weight,Reductions, Weight,Weight Losses,Weight Reductions

Related Publications

K Van Hoorenbeeck, and H Franckx, and P Debode, and P Aerts, and J Ramet, and L F Van Gaal, and K N Desager, and W A De Backer, and S L Verhulst
Sleep-disordered breathing and the metabolic syndrome in overweight and obese children and adolescents.
June 2007, The Journal of pediatrics,
K Van Hoorenbeeck, and H Franckx, and P Debode, and P Aerts, and J Ramet, and L F Van Gaal, and K N Desager, and W A De Backer, and S L Verhulst
Sleep-disordered breathing is increased in obese adolescents with craniopharyngioma compared with obese controls.
May 2010, The Journal of clinical endocrinology and metabolism,
K Van Hoorenbeeck, and H Franckx, and P Debode, and P Aerts, and J Ramet, and L F Van Gaal, and K N Desager, and W A De Backer, and S L Verhulst
Association of visceral adiposity and systemic inflammation with sleep disordered breathing in normal weight, never obese adolescents.
May 2020, Sleep medicine,
K Van Hoorenbeeck, and H Franckx, and P Debode, and P Aerts, and J Ramet, and L F Van Gaal, and K N Desager, and W A De Backer, and S L Verhulst
Sleep-disordered breathing before and after lung transplantation.
May 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
K Van Hoorenbeeck, and H Franckx, and P Debode, and P Aerts, and J Ramet, and L F Van Gaal, and K N Desager, and W A De Backer, and S L Verhulst
Sleep-disordered breathing and pulmonary function in obese children and adolescents.
August 2014, Sleep medicine,
K Van Hoorenbeeck, and H Franckx, and P Debode, and P Aerts, and J Ramet, and L F Van Gaal, and K N Desager, and W A De Backer, and S L Verhulst
Sleep-disordered breathing, systemic adipokine secretion, and metabolic dysregulation in overweight and obese children and adolescents.
February 2017, Sleep medicine,
K Van Hoorenbeeck, and H Franckx, and P Debode, and P Aerts, and J Ramet, and L F Van Gaal, and K N Desager, and W A De Backer, and S L Verhulst
Association between metabolic syndrome and sleep-disordered breathing in adolescents.
August 2007, American journal of respiratory and critical care medicine,
K Van Hoorenbeeck, and H Franckx, and P Debode, and P Aerts, and J Ramet, and L F Van Gaal, and K N Desager, and W A De Backer, and S L Verhulst
Metabolic fuel utilisation in obese women before and after weight loss.
March 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity,
K Van Hoorenbeeck, and H Franckx, and P Debode, and P Aerts, and J Ramet, and L F Van Gaal, and K N Desager, and W A De Backer, and S L Verhulst
Polysomnography before and after weight loss in obese patients with severe sleep apnea.
September 2005, International journal of obesity (2005),
K Van Hoorenbeeck, and H Franckx, and P Debode, and P Aerts, and J Ramet, and L F Van Gaal, and K N Desager, and W A De Backer, and S L Verhulst
The effect of weight loss on sleep-disordered breathing and oxygen desaturation in morbidly obese men.
September 1982, Chest,
Copied contents to your clipboard!